跳至主要内容
临床试验/NCT03488446
NCT03488446Unknown不适用

Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer(RPLNM)(GIPMCS-1701)

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2017年8月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Pathological lymph node status of every station

研究概览

简要总结

This study proposes to establish a CT radiomics-based prediction model for identifying metastasis of each station lymph nodes in gastric cancer.

详细描述

This is a prospective, multi-center trial conducted at 4 high-volume gastric cancer centers in China (Nanfang Hospital of Southern Medical University; Sun Yat-Sen University Cancer Center; First Affiliated Hospital, Sun Yat-Sen University; The Third Affiliated Hospital, Sun Yat-Sen University) designed to determine the predicted performance of radiomics-based prediction model for identifying metastasis of each station lymph nodes by enhanced CT for preoperative noninvasive assessment of the lymph node status in patients with gastric cancer. The study includes the construction of CT radiomics-based prediction model and the validation of the prediction model.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years;
  • Patients providing written informed consent;
  • Pathologically proven gastric cancer scheduled to preoperative enhanced abdomen CT and undergo gastrectomy with type D2 lymphadenectomy;
  • Has undergone > 64 multi-detector row CT within 14 days prior to surgical resection; .No receipt of preoperative therapy (radiotherapy, chemotherapy or chemoradiotherapy).

排除标准

  • Preoperative therapy (radiotherapy, chemotherapy or chemoradiotherapy);
  • Failed to receive preoperative enhanced abdomen CT or undergo gastrectomy with type D2 lymphadenectomy;
  • Inavailable pathological results for local lymph node status;
  • Inquality of CT images for feature extraction; .Patient quit.

结局指标

主要结局

Pathological lymph node status of every station

时间窗: Pathologic evaluation will be performed for each patient within 1 week after surgery

Pathological lymph node status of each station is defined as lymph node metastasis exist or not

次要结局

  • Survival time(Follow-up from the date of surgery to the date of death.)
  • Lymph node stage (N stage)(Pathologic evaluation will be performed for each patient within 1 week after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验